Report Update Nov 1, 2024

Portugal - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Portugal: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Portugal

The Portuguese medicaments containing insulin market rose remarkably to $X in 2021, with an increase of 8.6% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, consumption posted buoyant growth. As a result, consumption reached the peak level of $X. From 2018 to 2021, the growth of the market remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from Portugal

In 2021, the amount of medicaments containing insulin but not antibiotics exported from Portugal was estimated at X kg, approximately mirroring the previous year. Overall, exports recorded a precipitous shrinkage. The pace of growth was the most pronounced in 2016 with an increase of 349%. Over the period under review, the exports attained the maximum at X tons in 2013; however, from 2014 to 2021, the exports stood at a somewhat lower figure.

In value terms, medicaments containing insulin exports stood at $X in 2021. Over the period under review, exports saw a significant curtailment. The growth pace was the most rapid in 2016 when exports increased by 756% against the previous year. The exports peaked at $X in 2013; however, from 2014 to 2021, the exports failed to regain momentum.

Exports by Country

Angola (X kg) was the main destination for medicaments containing insulin exports from Portugal, with a 95% share of total exports. Moreover, medicaments containing insulin exports to Angola exceeded the volume sent to the second major destination, Mozambique (X kg), more than tenfold.

From 2012 to 2021, the average annual rate of growth in terms of volume to Angola totaled +18.9%.

From 2012 to 2021, the average annual growth rate of value to Angola stood at +30.0%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, remaining stable against the previous year. In general, the export price continues to indicate a mild slump. The pace of growth was the most pronounced in 2016 an increase of 92% against the previous year. The export price peaked at $X per ton in 2017; however, from 2018 to 2021, the export prices failed to regain momentum.

There were significant differences in the average prices for the major export markets. In 2021, amid the top suppliers, the country with the highest price was Angola ($X per ton), while the average price for exports to Mozambique stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Angola (+9.0%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Insulin Imports

Imports into Portugal

In 2021, approx. X tons of medicaments containing insulin but not antibiotics were imported into Portugal; growing by 13% compared with 2020 figures. Over the period under review, imports enjoyed a strong increase. The pace of growth appeared the most rapid in 2017 with an increase of 442%. As a result, imports attained the peak of X tons. From 2018 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing insulin imports expanded rapidly to $X in 2021. In general, imports showed buoyant growth. The most prominent rate of growth was recorded in 2017 when imports increased by 630% against the previous year. As a result, imports reached the peak of $X. From 2018 to 2021, the growth of imports failed to regain momentum.

Imports by Country

In 2021, Denmark (X tons) was the main medicaments containing insulin supplier to Portugal, accounting for a 97% share of total imports. It was followed by France (X kg), with a 2.5% share of total imports.

From 2012 to 2021, the average annual growth rate of volume from Denmark totaled +17.9%.

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Portugal, comprising 94% of total imports. The second position in the ranking was taken by France ($X), with a 5.8% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of value from Denmark amounted to +12.5%.

Import Prices by Country

In 2021, the average medicaments containing insulin import price amounted to $X per ton, with a decrease of -3% against the previous year. Overall, the import price continues to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2017 when the average import price increased by 35% against the previous year. As a result, import price reached the peak level of $X per ton. From 2018 to 2021, the average import prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was France ($X per ton), while the price for Denmark amounted to $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Austria (+7.4%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin consumption was Denmark, comprising approx. 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. The third position in this ranking was occupied by Pakistan, with a 3.6% share.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The U.S. remains the largest medicaments containing insulin producing country worldwide, accounting for 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to Portugal?

In value terms, Denmark constituted the largest supplier of medicaments containing insulin to Portugal, comprising 66% of total imports. The second position in the ranking was occupied by Germany, with a 20% share of total imports. It was followed by Austria, with a 6% share.

What are the leading importers of medicaments containing insulin but not antibiotics from Portugal?

In value terms, Germany remains the key foreign market for medicaments containing insulin exports from Portugal, comprising 98% of total exports. The second position in the ranking was occupied by Angola $875), with a 1.8% share of total exports.

What is the average export price for medicaments containing insulin but not antibiotics in Portugal?

The average medicaments containing insulin export price stood at $4,719 per ton in 2019, falling by -58.4% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in Portugal?

The average medicaments containing insulin import price stood at $187,821 per ton in 2020, shrinking by -6.6% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Portugal. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Portugal

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Portugal
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023